ConductScience.org, home

Trial · NCT04882072

Participant flow12

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Double Blind: Week 0 to Week 71.1STARTEDPlacebo Then Ustekinumab8
Double Blind: Week 0 to Week 71.1STARTEDUstekinumab Then Ustekinumab6
Double Blind: Week 0 to Week 71.1COMPLETEDPlacebo Then Ustekinumab6
Double Blind: Week 0 to Week 71.1COMPLETEDUstekinumab Then Ustekinumab6
Double Blind: Week 0 to Week 71.1NOT COMPLETEDPlacebo Then Ustekinumab2
Double Blind: Week 0 to Week 71.1NOT COMPLETEDUstekinumab Then Ustekinumab0
OL Extension: OL Week 0 to OL Week 63.1STARTEDPlacebo Then Ustekinumab3
OL Extension: OL Week 0 to OL Week 63.1STARTEDUstekinumab Then Ustekinumab4
OL Extension: OL Week 0 to OL Week 63.1COMPLETEDPlacebo Then Ustekinumab3
OL Extension: OL Week 0 to OL Week 63.1COMPLETEDUstekinumab Then Ustekinumab3
OL Extension: OL Week 0 to OL Week 63.1NOT COMPLETEDPlacebo Then Ustekinumab0
OL Extension: OL Week 0 to OL Week 63.1NOT COMPLETEDUstekinumab Then Ustekinumab1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04882072/flow